Gainers
- MaxCyte (NASDAQ:MXCT) shares rose 26.5% to $4.97 during Wednesday's regular session. The company's market cap stands at $519.4 million. The company's, Q1 earnings came out yesterday.
- Elanco Animal Health (NYSE:ELAN) stock moved upwards by 25.25% to $16.93. The market value of their outstanding shares is at $8.3 billion. The company's, Q1 earnings came out today.
- Globus Medical (NYSE:GMED) shares rose 22.17% to $62.75. The company's market cap stands at $8.4 billion. The company's, Q1 earnings came out yesterday.
- Clover Health Investments (NASDAQ:CLOV) stock moved upwards by 20.63% to $0.89. The company's market cap stands at $442.6 million. As per the press release, Q1 earnings came out yesterday.
- Vigil Neuroscience (NASDAQ:VIGL) stock moved upwards by 17.86% to $3.76. The company's market cap stands at $141.3 million. As per the press release, Q1 earnings came out yesterday.
- Syra Health (NASDAQ:SYRA) stock rose 17.35% to $1.76. The company's market cap stands at $11.6 million.
Losers
- Treace Medical Concepts (NASDAQ:TMCI) shares fell 62.3% to $4.19 during Wednesday's regular session. The company's market cap stands at $259.5 million. The company's, Q1 earnings came out yesterday.
- Inspire Medical Systems (NYSE:INSP) shares decreased by 34.69% to $160.44. The market value of their outstanding shares is at $4.8 billion. The company's, Q1 earnings came out yesterday.
- Definitive Healthcare (NASDAQ:DH) shares declined by 31.52% to $4.96. The company's market cap stands at $584.8 million. The company's, Q1 earnings came out yesterday.
- Seres Therapeutics (NASDAQ:MCRB) stock declined by 30.64% to $0.77. The company's market cap stands at $116.2 million. As per the news, the Q1 earnings report came out today.
- SIGA Technologies (NASDAQ:SIGA) shares fell 22.47% to $8.11. The market value of their outstanding shares is at $576.7 million. As per the press release, Q1 earnings came out yesterday.
- Semler Scientific (NASDAQ:SMLR) stock fell 21.25% to $22.17. The market value of their outstanding shares is at $155.8 million. The company's, Q1 earnings came out yesterday.
This article was generated by Benzinga's automated content engine and reviewed by an editor.